Somatic mutations of FLT3 are among the most common mutations in AML, with a prevalence of 10 to 20% in children and AYAs with AML, including acute promyelocytic leukemia (APL) [110,111,112,113,114]. Here, FLT3 is linked to acute myeloid leukemia.